STOCK TITAN

InMode to Present at Upcoming Investor Conferences and Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
InMode Ltd. announces participation in investor conferences and events in September.
Positive
  • None.
Negative
  • None.

YOKNEAM, Israel, Sept. 5, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in September:

Baird Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer and Dr. Spero Theodorou, Chief Medical Officer
Format: In-person fireside chat moderated by Jeff Johnson, Senior Equity Analyst, and one-on-one meetings
Location: New York, NY
When: Tuesday, Sept. 12 at 11:25 am ET
A live webcast of the presentation can be accessed here.

Piper Sandler Aesthetics Day
Presenters: Yair Malca, Chief Financial Officer, Wanda Cummings, RN and Vice President of Clinical Operations, North America and Dr. Christopher Chia, double board-certified Plastic Surgeon and Surgical Director of bodySCULPT
Format: In-person investor bus tour and demo at bodySCULPT, an InMode certified plastic and cosmetic surgery center in NYC
Location: New York, NY
When: Wednesday, Sept. 27 at 1:00 pm ET

Cantor Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Ross Osborn, Senior Equity Analyst, and one-on-one meetings
Location: New York, NY
When: Thursday, Sept. 28 at 10:55 am ET
A live webcast of the presentation can be accessed here.

About InMode 
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654 

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-and-events-301916514.html

SOURCE InMode Ltd.

InMode Ltd.

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Stock Data

1.56B
75.70M
9.69%
65.69%
6.98%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
Yokne'am

About INMD

inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and contraction. lumecca: broad spectrum pulsed light for rejuvenation of photo-damaged skin in a wide variety of skin types. diolaze: ultra fast diode hair removal featuring simultaneous 3pc (pre, parallel, and post cooling) technology and state of the art pulsing and power. bodyfx: non-invasive body contouring for buttocks, abdomen, flanks and thighs with a.c.e. technology